Skip to content

The effect of orally applied encapsulated lipids in yoghurt on satiety and food intake: a randomized single-blind study with cross-over design

The effect of orally applied encapsulated lipids in yoghurt on satiety and food intake: a randomized single-blind study with cross-over design - Lipid encapsulation for ileal brake activation

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43311
Enrollment
35
Registered
2016-12-21
Start date
2017-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity overweight

Interventions

Every subject receives two treatments on two different days with at least one week in between, following a randomized cross-over design. On the test day, the subjects will arrive in fasted state and
same oil droplet size as intervention and in presence of *empty* encapsulation matrix). Two hours after the intervention yoghurt, once the lipid will be released to the distal small intestine, ad l
encapsulation
ileal brake
slow release

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: BMI (25-30), healthy (Based on medical history and previous examination, no serious gastrointestinal complaints can be defined)

Exclusion criteria

Exclusion criteria: milk allergy/intollerance, dieting, pregnancy/lactation, excessive alcohol consumption, intention to stop smoking, severe disease, major abdominal surgery, abnormal eating behaviour

Design outcomes

Primary

MeasureTime frame
To investigate whether encapsulation of lipids decreases ad libitum food intake compared to non-encapsulated lipids in a formulation with equal nutrients (control).

Secondary

MeasureTime frame
- Feelings of satiety (VAS scores) - Occurance and severity of GI symptoms (VAS scores) - Yoghurt type specific differences in food intake, satiety and adverse GI symptoms

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)